Kris Kaneta
Bio
I’ve spent my career leading products and businesses at the intersection of healthcare, data and technology, with roles across GE HealthCare, TeleTracking, MMIT and now Norstella. That experience has taught me that technology alone isn’t enough. The real advantage comes from combining powerful AI with the context, expertise and data needed to solve complex problems.
What makes Norstella’s AI different?
The industry is focused on model intelligence, but model intelligence isn’t the same as contextual intelligence. We’ve spent decades building the context layer behind pharma’s most important decisions, and that is what allows our AI agents to deliver answers, recommendations and workflows that reflect how the industry actually operates.
What can pharma teams do now that was not possible two years ago?
We’re moving beyond AI that retrieves information to AI that can work through complex workflows and generate strategic recommendations. That means teams can spend less time gathering, reconciling and validating data, and more time evaluating options, making decisions and taking action.
How can AI accelerate the journey from pipeline to patient?
Every delay in drug development is ultimately a delay in getting therapies to patients. By combining AI with connected clinical, commercial and real-world data, we can shorten the time between question and decision, helping teams identify opportunities, evaluate trade-offs and move faster with greater confidence.